Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,117 across all filing types
Latest filing 2025-03-05 Major Shareholding Noti…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Ceasing to be a substantial holder 3 pages 554.6KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and references the Corporations Act 2001 Section 671B, which pertains to notices of ceasing to be a substantial holder. The content details changes in relevant interests and associations related to substantial shareholdings, including dates and parties involved. There is no financial data, earnings information, or management discussion. The document is a regulatory notice about shareholding changes, specifically a cessation of substantial holding, which fits the category of Major Shareholding Notification filings. Therefore, the appropriate classification is MRQ (Major Shareholding Notification). The document length is 5820 characters, sufficient to contain substantive content, not just an announcement or certification, supporting this classification.
2025-03-05 English
Becoming a substantial holder 12 pages 285.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under Corporations Law Section 671B. It details the substantial shareholding of UBS Group AG and its related bodies corporate in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. The document includes detailed tables of share transactions and agreements related to prime brokerage. This type of filing is a notification of a major shareholding change, specifically the crossing of a substantial holding threshold. It is not a financial report, earnings release, or management information. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2025-03-04 English
Becoming a substantial holder from MS 48 pages 3.3MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001, Section 671B, which pertains to notices of initial substantial holders. The content details the substantial shareholding of Morgan Stanley and its subsidiaries in Mayne Pharma Group Limited, including voting power, relevant interests, registered holders, and consideration paid for shares. This type of filing is a notification of a major shareholding or change in significant share ownership levels, consistent with the definition of Major Shareholding Notification (MRQ). The document is lengthy and contains detailed shareholding data, not just an announcement or summary, confirming it is the actual notification filing.
2025-02-27 English
Ceasing to be a substantial holder 1 page 219.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests of a substantial shareholder, including dates and amounts of share purchases and sales. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is not a financial report, management report, or regulatory announcement unrelated to shareholding. Therefore, the correct classification is MRQ.
2025-02-27 English
Change in substantial holding from MUFG 4 pages 900.1KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001 Section 671B, which pertains to notices of change of interests of substantial holders. The content details changes in voting power, relevant interests, and associations related to a substantial shareholder (Mitsubishi UFJ Financial Group, Inc.) in Mayne Pharma Group Limited. It includes specifics about share purchases and sales, voting rights, and related agreements. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is not a financial report, earnings release, or management information, but a regulatory notice about shareholding changes.
2025-02-27 English
Becoming a substantial holder from MUFG 29 pages 1.5MB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under the Corporations Act 2001, titled 'Notice of initial substantial holder'. It details the substantial shareholding of Mitsubishi UFJ Financial Group, Inc. in Mayne Pharma Group Limited, including voting power percentages, relevant interests, registered holders, and associates. This type of filing is a notification of a major shareholding level crossing a threshold, which aligns with the definition of 'Major Shareholding Notification'. The document is not a financial report, earnings release, or management report, but a regulatory disclosure of share ownership. Therefore, the appropriate classification is 'MRQ' for Major Shareholding Notification.
2025-02-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.